# LG EXAONE Shows Off Real-World AI at ICML 2026 in Seoul

> LG used ICML 2026 in Seoul to make a case that Korea's EXAONE models are already doing useful work, not just posting benchmark scores. The headline example was EXAONE Discovery, which screened 420,000 compounds in a single day and surfaced Rhamsydril, a new hair-loss care ingredient, by reading the scientific literature and proposing candidates. The rest of the lineup leans practical too. EXAONE Business Intelligence analyzes around 8,000 listed companies daily across Korea and the US to generate predictive investment scores, while EXAONE Data Foundry claims to boost data productivity more than a thousandfold by automatically generating training datasets. LG brought 14 papers to the conference, and its materials-generation model placed second globally on the LeMat-GenBench benchmark. The interesting thread here is who is doing applied AI. While US headlines fixate on frontier chatbots, a Korean electronics conglomerate is quietly pointing the same technology at materials science and drug leads, and getting shippable results.

_Section: [Daily AI Updates](https://www.wortins.com/daily-ai) · Source: Korea Times · Published Thursday, July 9, 2026_

## Wortins' read

LG used ICML 2026 in Seoul to make a case that Korea's EXAONE models are already doing useful work, not just posting benchmark scores. The headline example was EXAONE Discovery, which screened 420,000 compounds in a single day and surfaced Rhamsydril, a new hair-loss care ingredient, by reading the scientific literature and proposing candidates. The rest of the lineup leans practical too. EXAONE Business Intelligence analyzes around 8,000 listed companies daily across Korea and the US to generate predictive investment scores, while EXAONE Data Foundry claims to boost data productivity more than a thousandfold by automatically generating training datasets. LG brought 14 papers to the conference, and its materials-generation model placed second globally on the LeMat-GenBench benchmark. The interesting thread here is who is doing applied AI. While US headlines fixate on frontier chatbots, a Korean electronics conglomerate is quietly pointing the same technology at materials science and drug leads, and getting shippable results.

## Source

[Read the full story at Korea Times](https://www.koreatimes.co.kr/amp/business/tech-science/20260708/lg-ai-research-showcases-real-world-exaone-ai-applications-at-icml-2026)

## Related coverage

- [U.S. Commerce Department Sets National Security Review Gates for Frontier AI](https://www.wortins.com/story/u-s-commerce-department-sets-national-security-review-gates--59442244) — [McDermott Will & Emery](https://www.mcdermottlaw.com/insights/new-executive-order-shifts-us-ai-policy-toward-national-security/)
- [Together AI Raises $800M Series C at $8.3B Valuation](https://www.wortins.com/story/together-ai-raises-800m-series-c-at-8-3b-valuation-0d1883df) — [TechCrunch](https://techcrunch.com/2026/07/01/neocloud-together-ai-raises-800m-leaps-to-8-3b-valuation/)
- [HyNote](https://www.wortins.com/story/hynote-68bce936) — [HyNote](https://hynote.ai/)
- [AI Labs' Model Size Race Reveals Diminishing Returns on Scaling](https://www.wortins.com/story/ai-labs-model-size-race-reveals-diminishing-returns-on-scali-554dadde) — [TechTimes](https://www.techtimes.com/articles/324514/20260814/gpt-56-sol-now-runs-real-time-speed-openais-ultrafast-preview-offers-no-price-or-date.htm)
- [Stripe Acquires OpenRouter for $7 Billion+](https://www.wortins.com/story/stripe-acquires-openrouter-for-7-billion-09e913cf) — [Stripe](https://stripe.com/newsroom/news/stripe-agrees-to-acquire-openrouter)
- [OpenAI Expected to File Public S-1 for IPO in August 2026](https://www.wortins.com/story/openai-expected-to-file-public-s-1-for-ipo-in-august-2026-669b2648) — [Ind Money](https://www.indmoney.com/blog/us-stocks/openai-ipo-valuation-financials-risks)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._